Duopharma Biotech Bhd
KLSE:DPHARMA
Duopharma Biotech Bhd
Income from Continuing Operations
Duopharma Biotech Bhd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Income from Continuing Operations
myr56.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Income from Continuing Operations
myr3.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
0%
|
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Income from Continuing Operations
myr76.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Income from Continuing Operations
myr13m
|
CAGR 3-Years
1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Income from Continuing Operations
myr27m
|
CAGR 3-Years
21%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Income from Continuing Operations
myr40m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
17%
|
|
Duopharma Biotech Bhd
Glance View
Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.
See Also
What is Duopharma Biotech Bhd's Income from Continuing Operations?
Income from Continuing Operations
56.1m
MYR
Based on the financial report for Sep 30, 2024, Duopharma Biotech Bhd's Income from Continuing Operations amounts to 56.1m MYR.
What is Duopharma Biotech Bhd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
6%
Over the last year, the Income from Continuing Operations growth was -9%. The average annual Income from Continuing Operations growth rates for Duopharma Biotech Bhd have been -5% over the past three years , -1% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet